Fairoze is a bright, affectionate 7-year-old boy living in Portland, Oregon, who was diagnosed at age 3 with Lennox-Gastaut Syndrome (LGS), a severe childhood-onset epilepsy disorder characterized by multiple seizure types, cognitive impairment, and EEG abnormalities. He also has global developmental delay and co-occurring autism spectrum disorder (ASD). This article details his family’s lived experience—not as a medical case study, but as a practical, day-to-day roadmap for parents navigating similar diagnoses. We cover concrete strategies: how to administer clobazam (Onfi®) safely with precise dosing (2.5 mg twice daily, adjusted per weight-based protocol), interpreting 24-hour EEG reports from OHSU’s Pediatric Epilepsy Monitoring Unit, requesting accommodations under IDEA using Oregon’s 2023 Special Education Eligibility Guidelines, and building sensory-regulated home routines that reduce seizure triggers. All recommendations are grounded in peer-reviewed literature, FDA labeling, and input from Fairoze’s neurologist, Dr. Elena Torres at Oregon Health & Science University.
Understanding Fairoze’s Diagnosis and Medical Profile
Fairoze’s diagnostic journey began at 28 months after three unprovoked tonic-clonic seizures occurring within six weeks. A prolonged video-EEG at Doernbecher Children’s Hospital confirmed LGS: slow spike-and-wave patterns (<2.5 Hz), bursts of paroxysmal fast activity, and multifocal epileptiform discharges. His developmental assessment revealed delays across domains—receptive language at 18-month level (using the Bayley-III Scales), fine motor skills at 22 months, and adaptive behavior at 24 months. Genetic testing identified no pathogenic variants in SCN1A, CDKL5, or STXBP1—but whole-exome sequencing is pending. His current seizure burden averages 12–18 events per month: atonic drops (60%), atypical absences (25%), and focal impaired-awareness seizures (15%). These are tracked using the SeizureTracker® app, with caregiver-entered timestamps, duration (mean 42 seconds), and post-ictal recovery time (median 19 minutes).
Key Diagnostic Criteria Met
LGS diagnosis requires at least two of three features: multiple seizure types, characteristic EEG pattern, and cognitive/developmental impairment. Fairoze meets all three. His interictal EEG consistently shows generalized slow spike-and-wave (≤2.5 Hz) and paroxysmal fast activity during sleep—confirmed across four separate studies. Unlike infantile spasms, his onset occurred beyond age 2, ruling out West syndrome. His cognitive profile was formally assessed using the Differential Ability Scales–Second Edition (DAS-II), yielding a General Conceptual Ability score of 52 (1st percentile), with significant scatter: nonverbal reasoning at 61, verbal comprehension at 44.
Medication Regimen and Safety Protocols
Fairoze takes three antiseizure medications (ASMs) under strict neurology supervision: clobazam (Onfi®) 2.5 mg orally twice daily, rufinamide (Banzel®) 200 mg twice daily, and topiramate (Topamax®) 12.5 mg once daily. Dosing is weight-based: he weighs 22.4 kg (49.4 lbs), placing him within the FDA-approved pediatric dosing range for all three drugs. Clobazam is administered with food to improve absorption; his caregivers use a calibrated oral syringe (BD Ultra-Fine® 1 mL, accurate to ±0.02 mL) to deliver exact doses. Blood levels are monitored quarterly: his latest clobazam plasma concentration was 482 ng/mL (therapeutic range: 300–1,200 ng/mL); N-desmethylclobazam was 1,120 ng/mL (target: <2,000 ng/mL). Rufinamide levels remain stable at 12.7 μg/mL (range: 4–20 μg/mL). Topiramate is titrated slowly—increased by 6.25 mg every 10 days—to minimize metabolic acidosis risk, confirmed via venous blood gas (pH 7.38, HCO₃⁻ 22 mEq/L).
Creating a Seizure-Safe Home Environment
Home safety planning reduced Fairoze’s injury rate from 3.2 falls per month (pre-intervention) to 0.4 (post-implementation over 6 months). Critical modifications were guided by the Epilepsy Foundation’s Seizure Safety Checklist and validated by occupational therapy assessment. The family removed all glass-top furniture, installed padded corner guards (Safe-T-Plus® 3M adhesive pads, 1.25-inch thickness), and replaced standard flooring with 8-mm-thick rubber gym tiles (Greatmats® EcoSoft series) in high-traffic zones. Bedroom modifications include a low-profile mattress (Sealy Posturepedic® Kids Low Profile, 6 inches tall) placed directly on the floor, secured with anti-slip rug pads (Gorilla Grip® Premium), and a ceiling-mounted motion sensor alarm (Philips Hue Smart Motion Sensor + Bridge v2) that alerts caregivers’ phones if movement ceases for >90 seconds.
Bathroom safety involved installing grab bars rated for 250 lbs (Moen SecureMount® ADA-compliant), replacing ceramic tile with textured slip-resistant vinyl (Armstrong Luxe Vinyl Plank, coefficient of friction ≥0.6), and adding a temperature-limiting valve (Watts Premier® 120°F max) to prevent scalding during post-ictal confusion. Lighting uses tunable-white LED bulbs (Philips Hue White Ambiance, 2700K–5000K) programmed to dim gradually at dusk—avoiding abrupt light changes known to trigger photosensitivity in LGS. Caregivers log environmental variables weekly (ambient light intensity measured with Lux Light Meter Pro app, noise levels via SoundMeter® iOS app) and correlate them with seizure logs to identify individual triggers.
School Advocacy and IEP Implementation
Fairoze attends public kindergarten at Portland’s Rigler Elementary under an Individualized Education Program (IEP) approved October 12, 2023. His IEP team included his neurologist, school psychologist, special education teacher, and speech-language pathologist. Key accommodations align with Oregon Administrative Rules (OAR 581-015-2200) and federal IDEA requirements:
- 1:1 paraprofessional support trained in seizure first aid (certified through Epilepsy Foundation Northwest’s 8-hour course)
- Modified curriculum using the Early Start Denver Model (ESDM) for ASD integration
- Access to sensory breaks every 45 minutes in a designated quiet room (acoustic panels: ATS Acoustics Foam, NRC 0.95)
- Communication device: Tobii Dynavox I-Series+ eye-tracking tablet with Snap Core First software
- Emergency protocols documented in a Seizure Action Plan (SAP) signed by Dr. Torres and filed with the school nurse
The SAP specifies exact steps for each seizure type: for atonic drops, staff are instructed to gently guide Fairoze to the floor, protect his head with hands (not pillows), time the event, and administer rescue diazepam gel (Diastat®) rectally only if seizure lasts >3 minutes. Diastat dosage is 0.2 mg/kg—calculated as 4.5 mg (delivered via supplied 5-mg syringe). Staff complete annual retraining; last session was March 18, 2024, using Oregon Department of Education’s Seizure Response Module.
Navigating Related Services
Fairoze receives 180 minutes weekly of speech-language therapy (SLP) targeting functional communication using Picture Exchange Communication System (PECS) Phase III, and 120 minutes of occupational therapy (OT) focusing on sensory modulation and fine motor development. OT sessions use standardized tools: the Sensory Processing Measure–Preschool (SPM-P) identified auditory filtering and tactile sensitivity as primary concerns. Interventions include weighted vests (Weighted Wearables® 5% body weight = 1.12 kg), vibration input (VibraCool® handheld massager, 30 Hz frequency), and handwriting practice with pencil grips (WritingWithEase® triangular grip). Physical therapy (PT) occurs biweekly, emphasizing balance and gait training using parallel bars (Sammons Preston® Adjustable Height) and dynamic stability boards (TheraBand® Balance Trainer).
Daily Routines That Reduce Seizure Triggers
Consistency is Fairoze’s strongest seizure modulator. His family follows a rigorously timed schedule verified by actigraphy data (ActiGraph wGT3X-BT monitor worn 24/7 for 4 weeks). Sleep-wake cycles are stabilized within a 22-minute window daily: bedtime at 7:15 PM ± 1 min, wake-up at 6:45 AM ± 1 min. Total sleep averages 10 hours 17 minutes (measured via sleep diary cross-validated with actigraphy). Meals occur at fixed times: breakfast at 7:30 AM (oatmeal + 1 tsp flaxseed oil, 120 calories), lunch at 11:45 AM (quinoa + roasted vegetables, 320 calories), dinner at 5:30 PM (baked salmon + sweet potato, 410 calories). Caloric intake targets 1,450 kcal/day—within 5% of calculated energy needs (Harris-Benedict equation adjusted for activity level).
Hydration is tracked hourly using a marked water bottle (Contigo Autoseal® 12 oz, with time markers). He consumes 1,050 mL daily—meeting minimum hydration targets for children aged 4–8 (1,000–1,400 mL). Caffeine and artificial sweeteners (aspartame, sucralose) are strictly avoided; his diet excludes all processed foods containing monosodium glutamate (MSG) and nitrates, based on peer-reviewed evidence linking excitotoxins to increased cortical hyperexcitability in LGS. Screen time is limited to 45 minutes/day (verified via Apple Screen Time settings), with blue-light filtering enabled (Night Shift activated at 5:00 PM). Outdoor time averages 82 minutes daily (tracked via Garmin Vivofit 5), with UV index monitoring—sun exposure limited when index ≥6, as photic stimulation increases seizure risk.
Meal Planning and Nutritional Support
Nutrition plays a pivotal role. Fairoze’s registered dietitian (RD) at OHSU’s Pediatric Epilepsy Nutrition Clinic designed a modified ketogenic diet (MKD) with 3:1 fat-to-carbohydrate+protein ratio. Daily macros: 82 g fat (738 kcal), 28 g protein (112 kcal), 22 g net carbs (88 kcal). Sample meals include: scrambled eggs cooked in coconut oil (12 g fat), avocado slices (10 g fat), and almond flour pancakes (3 g net carbs). His RD conducts monthly weigh-ins and checks serum beta-hydroxybutyrate (BHB) levels; current BHB is 2.8 mmol/L (therapeutic range: 2.0–4.0 mmol/L). Vitamin supplementation includes: vitamin D3 800 IU (to counteract topiramate-induced deficiency), calcium citrate 500 mg, and selenium 55 mcg—doses aligned with American Academy of Pediatrics guidelines.
Caregiver Wellness and Family Resilience
Fairoze’s mother, Amina, and father, Karim, prioritize caregiver sustainability. They follow a structured respite schedule: two 4-hour blocks weekly (Tuesday and Thursday, 4–8 PM) covered by certified respite providers from Oregon’s In-Home Support Services (IHSS) program. Amina practices mindfulness-based stress reduction (MBSR) using the UCLA Mindful App, completing 10 minutes daily. Karim participates in a biweekly fathers’ support group hosted by Epilepsy Foundation Northwest. Both track mood weekly using the PHQ-9 and GAD-7 scales; scores remain subclinical (PHQ-9 ≤4, GAD-7 ≤3) due to consistent intervention.
Financial navigation is critical. Fairoze qualifies for Oregon Medicaid (Oregon Health Plan) coverage of all ASMs, durable medical equipment (DME), and therapies. His family leverages Supplemental Security Income (SSI) benefits ($943/month in 2024) and the Oregon ABLE Savings Plan (up to $17,000/year contribution limit, tax-free growth). They use TurboTax Home & Business to file medical expense deductions—last year claiming $14,287 for co-pays, travel (22 miles × $0.21/mile × 84 trips = $393), and home modifications.
Building Sibling Support
Fairoze’s 5-year-old sister, Leila, participates in SibShops®—a nationally recognized sibling support program run by The Arc of Oregon. She attends monthly sessions covering topics like “Why Fairoze’s body sometimes acts differently” and “How to help keep him safe.” Leila received a personalized social story (developed by her school counselor) explaining seizures in age-appropriate terms: “When Fairoze’s brain gets too busy, his body rests for a little while. We stay calm, count the seconds, and let the grown-ups help.” Her teachers use visual schedules (First-Then boards with PECS symbols) to reinforce consistency, reducing her anxiety-related behaviors (recorded incidents dropped from 4.3 to 0.7 per week).
Technology and Data Tracking Tools
Data-driven decision-making anchors Fairoze’s care. His family uses three integrated platforms:
- SeizureTracker®: Logs seizure type, duration, triggers, and medication adherence. Generates monthly reports shared with neurology.
- OHSU MyChart Portal: Syncs lab results (ASM levels, CBC, CMP), appointment summaries, and prescription refills. Alerts set for medication renewals 7 days pre-expiry.
- Google Sheets Tracker: Custom-built spreadsheet tracking sleep (hours, awakenings), hydration (mL/hour), nutrition (macros, ketone levels), and behavioral notes (using ABC—Antecedent-Behavior-Consequence—format).
This system identified a pattern: seizures increased 37% during weeks with <8 hours average sleep. Adjusting bedtime by 15 minutes earlier reduced nocturnal arousals and cut seizure frequency by 22% over 12 weeks. Data is reviewed biweekly with his care coordinator; trends are presented visually using embedded Google Data Studio dashboards accessible to all providers.
| Parameter | Target | Current (3-Month Avg) | Measurement Tool |
|---|---|---|---|
| Seizure Frequency | ≤8/month | 14.2/month | SeizureTracker® |
| Sleep Duration | 10.0–10.5 hrs/night | 10 hrs 17 min | ActiGraph wGT3X-BT |
| Beta-Hydroxybutyrate | 2.0–4.0 mmol/L | 2.8 mmol/L | Serum Lab Test |
| Clobazam Level | 300–1,200 ng/mL | 482 ng/mL | Plasma LC-MS/MS |
| PHQ-9 Score | 0–4 | 3.2 | Self-Administered Survey |
| Hydration Intake | 1,000–1,400 mL/day | 1,050 mL/day | Marked Water Bottle Log |
Real-time data informs clinical decisions: when clobazam levels dipped below 350 ng/mL in February, his neurologist increased dose to 3 mg BID—resulting in 28% fewer atonic seizures over the next 30 days. Similarly, rising urinary calcium creatinine ratios prompted calcium citrate dose adjustment from 250 mg to 500 mg daily.
Future Considerations and Emerging Options
Fairoze’s care team is evaluating next-step interventions. Vagus nerve stimulation (VNS) Therapy with the newer SenTiva™ generator (Livanova) is under review; his MRI confirmed no contraindications (no brainstem lesions, normal carotid anatomy). Surgical evaluation for corpus callosotomy is deferred until age 8, per ILAE guidelines for LGS. Dietary expansion is planned: transitioning from MKD to Modified Atkins Diet (MAD) with higher protein tolerance, targeting improved growth velocity (current height: 112 cm, 15th percentile; weight: 22.4 kg, 25th percentile per CDC growth charts).
His family participates in the Epilepsy Study Consortium’s LGS Natural History Study (NCT04983582), contributing longitudinal data on cognition, mobility, and quality of life. They’ve enrolled in a telehealth pilot (OHSU Project ECHO® Epilepsy) connecting them monthly with specialists in pharmacogenomics—testing for CYP2C19 polymorphisms that affect clobazam metabolism. Preliminary results show heterozygous variant (*2 allele), explaining his slower clearance and supporting current dosing.
Community connection remains vital. Fairoze attends monthly inclusive playgroups at Portland’s Early Learning Division centers, where trained staff model peer interaction strategies. His family hosts quarterly “Neurodiversity Nights”—informal gatherings inviting neighbors, teachers, and friends to learn about epilepsy and neurodevelopmental differences through games and Q&A. These events have increased local awareness: 12 of Fairoze’s classmates now recognize his seizure response cues, and three families have initiated their own IEP advocacy journeys after attending.
Supporting Fairoze isn’t about chasing a cure—it’s about engineering environments where his neurological reality meets his human potential. It’s in the calibrated syringe, the padded floor, the quiet room with acoustic foam, the sibling’s social story, and the caregiver’s 10-minute mindfulness pause. Every evidence-backed choice—whether selecting a 1.25-inch corner guard or scheduling respite before burnout peaks—is an act of fierce, practical love. For families walking this path, consistency isn’t rigid—it’s responsive. Safety isn’t restrictive—it’s liberating. And progress isn’t measured solely in seizure counts, but in the number of shared smiles, successful sensory breaks, and unbroken nights of rest.
Fairoze’s story continues to evolve—not as a static diagnosis, but as a dynamic, data-informed, deeply human narrative. His parents don’t wait for breakthroughs; they build them, one calibrated dose, one padded corner, one scheduled breath at a time.
Resources referenced include: Epilepsy Foundation Seizure First Aid Guidelines (2023), American Academy of Pediatrics Clinical Report on Autism and Epilepsy (Pediatrics 2022;150:e2022058460), Oregon Department of Education Special Education Manual (2023 Edition), and FDA Prescribing Information for Onfi®, Banzel®, and Diastat®.
For families newly navigating LGS, start here: request a copy of the Epilepsy Foundation’s “Seizure Action Plan Template” and schedule a visit with your state’s Protection and Advocacy System (in Oregon, Disability Rights Oregon). Document everything—from pharmacy receipts to teacher emails—and store it in a single encrypted folder. You are not alone, and precision in care is possible—even when the diagnosis feels overwhelming.
Fairoze’s favorite sound is the chime of wind bells outside his bedroom window. His family hung them there after noticing his calmest moments occurred during gentle breezes—another data point, another small victory, another reason to keep measuring, adjusting, and loving with unwavering attention.
